Publication

Anti-Retroviral Therapy Is Associated with Decreased Alveolar Glutathione Levels Even in Healthy HIV-Infected Individuals

Downloadable Content

Persistent URL
Last modified
  • 08/14/2025
Type of Material
Authors
    Sushma K Cribbs, Emory UniversityDavid M Guidot, Emory UniversityGreg Martin, Emory UniversityJeffrey L Lennox, Emory UniversityLou Ann Brown, Emory University
Language
  • English
Date
  • 2014
Publisher
  • Public Library of Science
Publication Version
Copyright Statement
  • This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1932-6203
Volume
  • 9
Issue
  • 2
Start Page
  • e88630
End Page
  • e88630
Grant/Funding Information
  • The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  • The work was supported by the following: National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454; and ACTSI KL2-Mentored Clinical and Translational Research Program and NIH KL2 support (KL2TR000454).
Abstract
  • Objective Lung infections are a leading cause of death in HIV-infected individuals. Measuring redox in HIV-infected individuals may identify those with chronic oxidative stress who are at increased risk for lung infection. We sought to estimate the association between HIV infection and oxidative stress in the lung, as reflected by decreased levels of glutathione and cysteine in the epithelial lining fluid. Methods Bronchoalveolar lavage (BAL) fluid was collected from healthy HIV-infected subjects and controls. Individuals were excluded if they had evidence of major medical co-morbidities, were malnourished or smoked cigarettes. Results We enrolled 22 otherwise healthy HIV and 21 non-HIV subjects. Among the HIV-infected subjects, 72.7% were on anti-retroviral therapy (ART) with a median CD4 count of 438 (279.8–599) and viral load of 0 (0–1.0) log copies/mL. There were no significant differences in median BAL fluid glutathione and cysteine levels between HIV and HIV-uninfected subjects. However, BAL glutathione was significantly higher in HIV-infected subjects on anti-retroviral therapy (ART) compared to those not on ART [367.4 (102–965.3) nM vs. 30.8 (1.0–112.1) nM, p = 0.008]. Further, HIV infection with ART was associated with an OR of 2.02 for increased BAL glutathione when adjusted for age and body mass index, whereas HIV infection without ART was associated with an OR of 2.17 for decreased BAL glutathione. Conclusion HIV infection without ART was associated with increased oxidative stress, as reflected by decreased alveolar glutathione levels, in otherwise healthy HIV-infected individuals. Further study needs to be done identify predictors of lung health in HIV and to address the role of ART in improving lung immunity.
Author Notes

Tools

Relations

In Collection:

Items